Mark Thursz
Imperial College London
H-index: 85
Europe-United Kingdom
Top articles of Mark Thursz
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Targeting IL-1 in severe alcohol-related hepatitis: How many frogs will we need to kiss to find an effective therapy? | Journal of Hepatology | Mark Thursz Philippe Mathurin | 2024/3/16 |
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis | The Lancet global health | Liem B Luong Nguyen Maud Lemoine Gibril Ndow Zachary J Ward Timothy B Hallet | 2024/1/1 |
Unmasking the silent threat—acute kidney injury in alcohol‐associated hepatitis. Authors' reply | Luke D Tyson Stephen Atkinson Robert W Hunter Mark Thursz Nikhil Vergis | 2024/1 | |
A prospective study on the prevalence of MASLD in people with type‐2 diabetes in the community. Cost effectiveness of screening strategies | Liver International | Roberta Forlano Tijana Stanic Sahan Jayawardana Benjamin Harvey Mullish Michael Yee | 2024/1 |
Disruption of gut barrier integrity and host–microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus | Gut Microbes | R Forlano L Martinez-Gili P Takis J Miguens-Blanco T Liu | 2024/12/31 |
Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis | Journal for Immunotherapy of Cancer | Cathrin LC Gudd Eoin Mitchell Stephen R Atkinson Marie-Anne Mawhin Samra Turajlic | 2024 |
Multi-tissue profiling of oxylipins reveal a conserved up-regulation of epoxide: diol ratio that associates with white adipose tissue inflammation and liver steatosis in obesity | EBioMedicine | Charlotte Hateley Antoni Olona Laura Halliday Matthew L Edin Jeong-Hun Ko | 2024/5/1 |
In severe alcohol‐related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL‐8 and … | Alimentary pharmacology & therapeutics | Luke D Tyson Stephen Atkinson Robert W Hunter Michael Allison Andrew Austin | 2023/12 |
Tu1866 SALIVARY MICROBIOTA COMPOSITION IS ASSOCIATED WITH ANTIBODY RESPONSE FOLLOWING COVID-19 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE, CIRRHOSIS AND LIVER … | Gastroenterology | Benjamin H Mullish Nathan P Danckert Ria Patel Sophie L Irwin Stavros Dimitriadis | 2023/5/1 |
Rapid point-of-care test for hepatitis B core-related antigen to diagnose high viral load in resource-limited settings | Clinical Gastroenterology and Hepatology | Yusuke Shimakawa Gibril Ndow Atsushi Kaneko Katsumi Aoyagi Maud Lemoine | 2023/7/1 |
Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease | EBioMedicine | Trishan Vaikunthanathan Emmanuelle Landmann Diana Marin Correa Marco Romano Silvia Cellone Trevelin | 2023/9/1 |
Advances in the understanding and management of alcohol-related liver disease | Mark Thursz Anne Lingford-Hughes | 2023/11/20 | |
Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers | 2023/4/20 | ||
The role of neutrophils in alcohol-related hepatitis | Reenam S Khan Patricia F Lalor Mark Thursz Phil Newsome | 2023/6/6 | |
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study | Blood Coagulation & Fibrinolysis | Yong Hoon Lee Seung-Ick Cha Kyung Min Shin Jae Kwang Lim Won Kee Lee | 2021/9/1 |
Immune Checkpoint Inhibitor-Induced Liver Injury | Cathrin LC Gudd Roosey Sheth Mark R Thursz Evangelos Triantafyllou Lucia A Possamai | 2023/11 | |
Prospective evaluation of screening strategies for NAFLD in people with type-2 diabetes mellitus in the community | Digestive and Liver Disease | R Forlano T Stanic S Jayawardana BH Mullish M Yee | 2023/3/1 |
Poor performance at five times sit-to-stand test, but not at handgrip test, is related to significant liver fibrosis and correlates with major cardiovascular events in non … | Journal of Hepatology | Giordano Sigon Roberta Forlano Benjamin H Mullish Jian Huang Michael Yee | 2023/6/1 |
Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2 | Journal of General Virology | Mark Thursz Fuzia Sadiq Julia A Tree Peter Karayiannis David WC Beasley | 2023/7/11 |
O6 The beneficial hepatic-effect of glucagon-like peptide 1 receptor agonists in diabetic patients with non-alcoholic fatty liver disease | Roberta Forlano Miss Huma Malik Giordano Sigon Miss Vicky Lin Jian Huang | 2023/9/1 |